NIH and Allscripts subsidiary 2bPrecise launch cloud-based genomic technology to boost precision medicine
2bPrecise, a wholly owned subsidiary of Allscripts Healthcare, has launched an early adopter program at the National Institutes of Health.
The NIH, a longtime Allscripts Sunrise EHR client, will deploy a cloud-based genomics and precision medicine platform designed by 2bPrecise.
2bPrecise uses advanced methods in clinical-genomic ontology and data harmonization and returns merged, semantically harmonized knowledge in a machine-readable and structured format, Allscripts executives explained. Medical researchers can combine genomic data with clinical and environmental information in a way that enables statistical analysis and pattern detection.
The 2bPrecise EHR-agnostic technology will make it possible for NIH physicians and researchers to use genomic information in their existing Allscripts Sunrise workflow. The goal is to simplify and optimize the complex process of finding, selecting, ordering and receiving genomic tests. Using the 2bPrecise genomics and precision medicine tools, results of genomic sequencing tests will be made available at the point of care through Allscripts Sunrise EHR.
Genomic medicine experts from NIH will be the early adopters and include physicians and researchers at the National Human Genome Research Institute, the National Cancer Institute and the NIH Clinical Center.
“2bPrecise will soon be able to take a big step toward bringing an easy-to-use, clinical-genomic solution into the mainstream," 2bPrecise General Manager Assaf Halevy said in a statement. He added the offering soon would be available to any provider, integrated delivery network or payer organization to help unlock new insights of molecular diagnostics and new treatments.